dichlorotetraamine(1,6-hexamethylenediamine)diplatinum(II): structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 3081728 |
| MeSH ID | M0164918 |
| Synonym |
|---|
| pt(ii)clda |
| bbr 3171 |
| tetraamminedichloro(mu-(1,6-hexanediamine-n:n'))diplatinum(2+) dichloride, stereoisomer |
| bbr 3005 |
| 125408-81-3 |
| platinum(2+), tetraamminedichloro(mu-(1,6-hexanediamine-n:n'))di-, dichloride, stereoisomer |
| dichlorotetraamine(1,6-hexamethylenediamine)diplatinum(ii) |
| DTXSID80925126 |
| platinum(2+) chloride--hexane-1,6-diamine--ammonia (2/4/1/4) |
| azane;hexane-1,6-diamine;platinum(2+);tetrachloride |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.80) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||